COPD management

Thematic Poster
Chairs: A. Mathioudakis (Manchester, United Kingdom), M. Cazzola (Roma (RM), Italy), H. Kerstjens (Groningen, Netherlands), I. Bonovolias (Thessaloniki, Greece)
Dual bronchodilator response according to bronchitis symptoms in the FLAME study
A. Mackay (London, United Kingdom), K. Kostikas (Basel, United Kingdom), S. Frent (Timisoara, Romania), K. Mezzi (Basel, United Kingdom), P. Pfister (Basel, United Kingdom), P. Gupta (Hyderabad, United Kingdom), F. Patalano (Basel, United Kingdom), D. Banerji (East Hanover, United Kingdom), J. Wedzicha (London, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Indacaterol/glycopyrronium vs tiotropium or glycopyrronium in treatment naive COPD patients: a pooled analysis
S. Muro (Kyoto, Japan), H. Yoshisue (Tokyo, Japan), A. Mackay (London, United Kingdom), K. Kostikas (Basel, Switzerland), P. Olsson (Taby, Sweden), P. Gupta (Hyderabad, India), J. Wedzicha (London, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Estimating potential cost savings associated with managing COPD according to GOLD 2017 recommendations in UK primary care: a CPRD study
A. Mathioudakis (Manchester, United Kingdom), J. Vestbo (Manchester, United Kingdom), A. Gayle (Bracknell, United Kingdom), S. Dickinson (Bracknell, United Kingdom), K. Morris (Bracknell, United Kingdom), S. Webster (Bracknell, United Kingdom), C. Poole (Bracknell, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Indacaterol/glycopyrronium increases lung ventilation in COPD patients as measured by hyperpolarized 3He MRI
H. Tillmann (Basel, Switzerland), D. Singh (Manchester, United Kingdom), D. Saralaya (Bradford, United Kingdom), R. Lawson (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), J. Goldin (Los Angeles, United States of America), K. Kostikas (Basel, Switzerland), K. Smith (Cambridge, United States of America), S. Machineni (Hyderabad, India), D. Yates (Cambridge, United States of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Effect of ICS withdrawal on COPD exacerbations in patients on triple therapy at baseline
G. Ferguson (Farmington Hills, United States of America), A. Shaikh (Ridgefield, United States of America), K. Tetzlaff (Biberach an der Riss, Germany), A. Mueller (Biberach an der Riss, Germany), H. Watz (Grosshansdorf, Germany)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Health status changes in COPD patients after real-life switch from tiotropium or salmeterol/fluticasone to indacaterol/glycopyrronium using the EQ-5D-3L instrument: results from the POWER study
S. Anees (Windsor, Canada), A. Mcivor (Hamilton, Canada), K. Chapman (Toronto, Canada), I. Mayers (Edmonton, Canada), D. Rochdi (Dorval, Canada), D. Prefontaine (Dorval, Canada), A. Kaplan (Toronto, Canada)
Congress or journal article abstract
Congress or journal article abstract
Extrafine beclometasone dipropionate, formoterol fumarate, glycopyrronium (BDP/FF/G) and exacerbation recurrence: post-hoc analysis of the TRIBUTE study.
L. Fabbri (Ferrara, Italy), D. Singh (Manchester, United Kingdom), J. Vestbo (Manchester, United Kingdom), M. Corradi (Parma, Italy), A. Guasconi (Parma, Italy), M. Scuri (Parma, Italy), G. Georges (Parma, Italy), I. Montagna (Parma, Italy), H. Prunier (Parma, Italy), S. Vezzoli (Parma, Italy), S. Petruzzelli (Parma, Italy), A. Papi (Ferrara, Italy)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Pharmacological treatment of stable Chronic Obstructive Pulmonary Disease: Where do we stand?
F. Chermiti Ben Abdallah (Ariana, Tunisia), M. Kacem (Ariana, Tunisia), I. Bachouch (Ariana, Tunisia), N. Belloumi (Ariana, Tunisia), Y. Hdidene (Ariana, Tunisia), S. Fenniche (Ariana, Tunisia)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
FF/UMEC/VI versus FF/VI and UMEC/VI in the ELLIPTA device in patients with COPD: Subgroup analyses from the IMPACT trial
D. Singh (Manchester, United Kingdom), F. Barnhart (Research Triangle Park, United States of America), N. Brealey (Uxbridge, United Kingdom), G. Criner (Philadelphia, United States of America), M. Dransfield (Birmingham, United States of America), D. Halpin (Exeter, United Kingdom), M. Han (Ann Arbor, United States of America), C. Jones (Research Triangle Park, United States of America), S. Kilbride (Uxbridge, United Kingdom), P. Lange (Copenhagen, Denmark), D. Lomas (London, United Kingdom), F. Martinez (New York, United States of America), D. Mouneimne (Brentford, United Kingdom), R. Wise (Baltimore, United States of America), D. Lipson (Philadelphia, United States of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Exacerbation outcomes with LAMA/LABA and ICS/LABA in high risk COPD patients in the IMPACT trial
D. Lipson (Pennsylvania, United States of America), F. Barnhart (Research Triangle Park, United States of America), I. Boucot (Brentford, United Kingdom), C. Crim (Research Triangle Park, United States of America), N. Brealey (Uxbridge, United Kingdom), G. Criner (Philadelphia, United States of America), M. Dransfield (Birmingham, United States of America), D. Halpin (Exeter, United Kingdom), S. Kilbride (Uxbridge, United Kingdom), M. Han (Ann Arbor, United States of America), P. Lange (Copenhagen, Denmark), D. Lomas (London, United Kingdom), F. Martinez (New York, United States of America), D. Singh (Manchester, United Kingdom), I. Naya (Brentford, United Kingdom), C. Jones (Research Triangle Park, United States of America), R. Wise (Baltimore, United States of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Comparison of LAMA/LABA vs ICS/LABA in high risk COPD patients: Pre-specified analysis on lung function and health status from the IMPACT trial
D. Lipson (Pennsylvania, United States of America), F. Barnhart (Research Triangle Park, United States of America), I. Boucot (Brentford, United Kingdom), C. Crim (Research Triangle Park, United States of America), N. Brealey (Uxbridge, United Kingdom), G. Criner (Philadelpha , United States of America), M. Dransfield (Birmingham , United States of America), D. Halpin (Exeter, United Kingdom), S. Kilbride (Uxbridge, United Kingdom), M. Han (Ann Arbor, United States of America), P. Lange (Copenhagen, Denmark), D. Lomas (London, United Kingdom), F. Martinez (New York, United States of America), D. Singh (Manchester, United Kingdom), I. Naya (Brentford, United Kingdom), C. Jones (Research Triangle Park, United States of America), R. Wise (Baltimore, United States of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
LABA/LAMA combinations efficacy evaluation therapy of COPD patients with emphasized morning and night symptoms
T. Pavlovic (Belgrade, Republic of Serbia), D. Pavlovic (Belgrade, Republic of Serbia), M. Vukcevic (Belgrade, Republic of Serbia), V. Žugic (Belgrade, Republic of Serbia)
Congress or journal article abstract
Congress or journal article abstract
Baseline symptom burden and dual bronchodilator response in the FLAME study
A. Mackay (London, United Kingdom), K. Kostikas (Basel, Switzerland), S. Frent (Timisoara, Romania), P. Olsson (Täby, Sweden), P. Pfister (Basel, Switzerland), P. Gupta (Hyderabad, India), F. Patalano (Basel, Switzerland), D. Banerji (East Hanover, United States of America), J. Wedzicha (London, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Indacaterol/Glycopyrronium improves pulmonary ventilation and ventilation inhomogeneity in the CLAIM Study
J. Vogel-Claussen (Hannover, Germany), T. Kaireit (Hannover, Germany), A. Voskrebenzev (Hannover, Germany), C. Schoenfeld (Hannover, Germany), C. Czerner (Hannover, Germany), J. Renne (Hannover, Germany), H. Tillmann (Basel, Switzerland), K. Berschneider (Nuremberg, Germany), S. Hiltl (Nuremberg, Germany), J. Bauersachs (Hannover, Germany), T. Welte (Hannover, Germany), J. Hohlfeld (Hannover, Germany)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Comparison of dual vs triple therapies in patients hospitalized for COPD in France: a claims data study
F. Dalon (Lyon, France), N. Roche (Paris, France), M. Belhassen (Lyon, France), M. Nolin (Lyon, France), D. Vesque (Bois-Colombes, France), P. Devillier (Suresnes, France), G. Deslee (Reims, France), B. Housset (Créteil, France), H. Pegliasco (Marseille, France), E. Van Ganse (Lyon, France)
Congress or journal article abstract
Congress or journal article abstract
Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study
Y. Minakata (Wakayama, Japan), T. Motegi (Tokyo, Japan), J. Ueki (Chiba, Japan), Y. Gon (Tokyo, Japan), T. Seki (Tokyo, Japan), T. Anzai (Tokyo, Japan), S. Nakamura (Tokyo, Japan), K. Hirata (Osaka, Japan), M. Ichinose (Sendai, Japan)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Effect of tiotropium/olodaterol combination therapy on long-term heart rate and blood pressure in COPD patients
S. Andreas (Göttingen, Germany), L. Mcgarvey (Belfast, United Kingdom), U. Bothner (Ingelheim am Rhein, Germany), M. Trampisch (Ingelheim am Rhein, Germany), A. De La Hoz (Ingelheim am Rhein, Germany), M. Fležar (Golnik, Slovakia), . Alter (Marburg, Germany), R. Buhl (Mainz, Germany)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Effects of Inhaled Long Acting Muscarinic Antagonist (LAMA) on Lung Functions in Adult Stable Bronchiectasis
M. Tungnantawiwat (Bangkok, Thailand), K. Kitinarong (Bangkok, Thailand)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
AMPLIFY: efficacy of aclidinium vs tiotropium in COPD
S. Sethi (Buffalo, United States of America), E. Kerwin (Medford, United States of America), H. Watz (Grosshansdorf, Germany), G. Ferguson (Farmington Hills, United States of America), R. Mroz (Bialystok, Poland), R. Segarra (Barcelona, Spain), E. Molins (Barcelona, Spain), D. Jarreta (Barcelona, Spain), E. Garcia-Gil (Barcelona, Spain)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials
D. Halpin (Exeter, United Kingdom), C. Vogelmeier (Marburg, Germany), A. Mackay (London, United Kingdom), K. Mezzi (Basel, Switzerland), P. Goyal (Basel, Switzerland), P. Gupta (Hyderabad, India), K. Kostikas (Basel, Switzerland), J. Wedzicha (London, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster